Pneumoconiosis other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Line 17: Line 17:
**Asbestos bodies can be identified to diagnose asbestosis  
**Asbestos bodies can be identified to diagnose asbestosis  
**Can be used to diagnose berylliosis with a beryllium lymphocyte proliferation test
**Can be used to diagnose berylliosis with a beryllium lymphocyte proliferation test
*Lung biopsy can be used to confirm the pneumoconiosis


==References==
==References==

Revision as of 16:09, 28 April 2021

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis other diagnostic studies

CDC on Pneumoconiosis other diagnostic studies

Pneumoconiosis other diagnostic studies in the news

Blogs on Pneumoconiosis other diagnostic studies

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

Pulmonary function tests, bronchoscopy, and lung biopsies may be helpful in the diagnosis of pneumoconiosis.

Other Diagnostic Studies

Other diagnostic studies for pneumoconiosis include: [1] [2] [3] [4] [5]

  • Pulmonary function tests (PFT), which demonstrates:
    • Decreased FEV1 and FEV1/FVC ratio
    • Decreased DLCO
    • Decreased compliance
  • Broncheoalveolar lavage:
    • Can be used to study cytology and exclude other pathologies
    • Asbestos bodies can be identified to diagnose asbestosis
    • Can be used to diagnose berylliosis with a beryllium lymphocyte proliferation test
  • Lung biopsy can be used to confirm the pneumoconiosis

References

  1. Wang XR, Christiani DC (2000). "Respiratory symptoms and functional status in workers exposed to silica, asbestos, and coal mine dusts". J Occup Environ Med. 42 (11): 1076–84. doi:10.1097/00043764-200011000-00009. PMID 11094786.
  2. Bégin R, Ostiguy G, Cantin A, Bergeron D (1988). "Lung function in silica-exposed workers. A relationship to disease severity assessed by CT scan". Chest. 94 (3): 539–45. doi:10.1378/chest.94.3.539. PMID 3409733.
  3. "American Thoracic Society. Medical Section of the American Lung Association: The diagnosis of nonmalignant diseases related to asbestos". Am Rev Respir Dis. 134 (2): 363–8. 1986. doi:10.1164/arrd.1986.134.2.363. PMID 3740660.
  4. De Vuyst P, Jedwab J, Dumortier P, Vandermoten G, Vande Weyer R, Yernault JC (1982). "Asbestos bodies in bronchoalveolar lavage". Am Rev Respir Dis. 126 (6): 972–6. doi:10.1164/arrd.1982.126.6.972. PMID 7181238.
  5. Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA; et al. (2014). "An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease". Am J Respir Crit Care Med. 190 (10): e34–59. doi:10.1164/rccm.201409-1722ST. PMID 25398119.

Template:WH Template:WS